Paclitaxel, estramustine and carboplatin combination chemotherapy after initial docetaxel-based chemotherapy in castration-resistant prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19420966

Download in:

View as

General Info

PMID
19420966